Cell biology of renal osteodystrophy

Pediatric Nephrology

Volumn 17, Issue 10, 2002, Pages 777-789

  Kuizon, Beatriz D ^a   Salusky, Isidro B ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b CHILDREN S HOSPITAL LOS ANGELES   (United States)

Author keywords

Adynamic renal osteodystrophy; Renal failure; Renal osteodystrophy; Secondary hyperparthyroidism

Indexed keywords

CALCITRIOL; CALCIUM; PARATHYROID HORMONE; PHOSPHORUS; VITAMIN D;

BONE TURNOVER; CHRONIC KIDNEY FAILURE; ENDOCRINE FUNCTION; HISTOPATHOLOGY; HUMAN; PARATHYROID HYPERPLASIA; PATHOGENESIS; PRIORITY JOURNAL; RENAL OSTEODYSTROPHY; REVIEW; SECONDARY HYPERPARATHYROIDISM; THYROID HORMONE RELEASE; THYROID HORMONE SYNTHESIS;

ANIMALS; BONE DISEASES; GROWTH PLATE; HUMANS; KIDNEY FAILURE; PARATHYROID GLANDS; RENAL OSTEODYSTROPHY;

EID: 0036952057     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-002-0919-x     Document Type: Review

References (145)

1. Salusky IB, Coburn JW, Brill J, Foley J, Slatopolsky E, Fine RN, Goodman WG (1988) Bone disease in pediatric patients undergoing dialysis with CAPD or CCPD. Kidney Int 33:975-982
2. Salusky IB, Ramirez JA, Oppenheim WL, Gales B, Segre GV, Goodman WG (1994) Biochemical markers of renal osteodystrophy in pediatric patients undergoing CAPD/CCPD. Kidney Int 45:253-258
3. Mathias RS, Salusky IB, Harmon WH, Paredes A, Emans J, Segre GV, Goodman WG (1993) Renal bone disease in pediatric patients and young adults treated by hemodialysis in a children's hospital. J Am Soc Nephrol 12:1938-1946
4. Sherrard DJ, Hercz G, Pei Y, Maloney N, Greenwood C, Manuel A, Saiphoo C, Fenton SS, Segre GV (1993) The spectrum of bone disease in end-stage renal failure - an evolving disorder. Kidney Int 43:436-442
5. Hercz G, Pei Y, Greenwood C, Manuel A, Saiphoo C, Goodman WG, Segre GV, Fenton S, Sherrard DJ (1993) Aplastic osteodystrophy without aluminum: the role of "suppressed" parathyroid function. Kidney Int 44:860-866
6. Torres A, Lorenzo V, Hernandez D, Rodriguez JC, Concepcion MT, Rodriguez AP, Hernandez A, De Bonis E, Darias E, Gonzales-Posada JM, et al. (1995) Bone disease in predialysis, hemodialysis, and CAPD patients: evidence of a better bone response to PTH. Kidney Int 47:1434-1442
7. Salusky IB, Kuizon BD, Belin T, Ramirez JA, Gales B, Segre GV, Goodman WG (1998) Intermittent calcitriol therapy in secondary hyperparathyroidism: a comparison between oral and intraperitoneal administration. Kidney Int 54:907-914
8. Goodman WG, Ramirez JA, Belin TR, Chon Y, Gales B, Segre GV, Salusky IB (1994) Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy. Kidney Int 46:1160-1166
9. Vasicek TJ, McDevitt BE, Freeman MW, Fennick BJ, Hendy GN, Potts JT Jr, Rich A, Kronenberg HM (1983) Nucleotide sequence of the human parathyroid hormone gene. Proc Natl Acad Sci U S A 80:2127-2131
10. Reis A, Hecht W, Groger R, Bohm I, Cooper DN, Lindenmaier W, Mayer H, Schmidtke J (1990) Cloning and sequence analysis of the human parathyroid hormone gene region. Hum Genet 84:119-124
11. Fraser RA, Kronenberg HM, Pang PK, Harvey S (1990) Parathyroid hormone messenger ribonucleic acid in the rat hypothalamus. Endocrinology 127:2517-2522
12. Gunther T, Chen ZF, Kim J, Priemel M, Rueger JM, Amling M, Moseley JM, Martin TJ, Anderson DJ, Karsenty G (2000) Genetic ablation of parathyroid glands reveals another source of parathyroid hormone. Nature 406:199-203
13. 3. Proc Natl Acad Sci U S A 89:8097-8101
14. Mackey SL, Heymont JL, Kronenberg HM, Demay MB (1996) Vitamin D receptor binding to the negative human parathyroid hormone vitamin D response element does not require the retinoid x receptor. Mol Endocrinol 10:298-305
15. Farrow SM, Hawa NS, Karmali R, Hewison M, Walters JC, O'Riordan JL (1990) Binding of the receptor for 1,25-dihydroxyvitamin D3 to the 5'-flanking region of the bovine parathyroid hormone gene. J Endocrinol 126:355-359
16. Hawa NS, O'Riordan JL, Farrow SM (1994) Binding of 1,25-dihydroxyvitamin D3 receptors to the 5'-flanking region of the bovine parathyroid hormone gene. J Endocrinol 142:53-60
17. Liu SM, Koszewski N, Lupez M, Malluche HH, Olivera A, Russell J (1996) Characterization of a response element in the 5'-flanking region of the avian (chicken) PTH gene that mediates negative regulation of gene transcription by 1,25-dihydroxyvitamin D3 and binds the vitamin D3 receptor. Mol Endocrinol 10:206-215
18. Okazaki T, Ando K, Igarashi T, Ogata E, Fujita T (1992) Conserved mechanism of negative gene regulation by extracellular calcium. Parathyroid hormone gene versus atrial natriuretic polypeptide gene. J Clin Invest 89:1268-1273
19. Okazaki T, Chung U, Nishishita T, Ebisu S, Usuda S, Mishiro S, Xanthoudakis S, Igarashi T, Ogata E (1994) A redox factor protein, ref1, is involved in negative gene regulation by extracellular calcium. J Biol Chem 269:27855-27862
20. 3 reduces spontaneous and hypocalcemia-stimulated pulsatile component of parathyroid hormone secretion. J Am Soc Nephrol 9:54-62
21. Grant FD, Conlin PR, Brown EM (1990) Rate and concentration dependence of parathyroid hormone dynamics during stepwise changes in serum ionized calcium in normal humans. J Clin Endocrinol Metab 71:370-378
22. Brent GA, Leboff MS, Seely EM, Conlin PR, Brown EM (1988) Relationship between the concentration and rate of change of serum calcium and serum intact parathyroid hormone levels in normal humans. J Clin Endocrinol Metab 67:944-950
23. Brown EM (1983) Four-parameter model of the sigmoidal relationship between parathyroid hormone release and extracellular calcium concentration in normal and abnormal parathyroid tissue. J Clin Endocrinol Metab 56:572-581
24. Ramirez JA, Goodman WG, Belin T, Gales B, Segre GV, Salusky IB (1994) Calcitriol therapy and calcium-regulated PTH secretion in patients with secondary hyperparathyroidism. Am J Physiol (Endocrinol Metab) 267:E961-E967
25. Brown EM, Pollak M, Seidman CE, Seidman JG, Chou YH, Riccardi D, Hebert SC (1995) Calcium-ion-sensing cell-surface receptors. N Engl J Med 333:234-240
26. Brown EM, MacLeod RJ (2001) Extracellular calcium sensing and extracellular calcium signaling. Physiol Rev 81:239-297
27. Pollak MR, Brown EM, Estep HL, McLaine PN, Kifor O, Park J, Hebert SC, Seidman CE, Seidman JG (1994) Autosomal dominant hypocalcaemia caused by a Ca(2+)-sensing receptor gene mutation. Nat Genet 8:303-307
28. 2+-sensing receptor gene causing familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Cell 75:1297-1303
29. Chou YH, Pollak MR, Brandi ML, Toss G, Arnqvist H, Atkinson AB, Papapoulos SE, Marx S, Brown EM, Seidman JG (1995) Mutations in the human Ca(2+)-sensing-receptor gene that cause familial hypocalciuric hypercalcemia. Am J Hum Genet 56:1075-1079
30. Ho C, Conner DA, Pollak MR, Ladd DJ, Kifor O, Warren HB, Brown EM, Seidman JG, Seidman CE (1995) A mouse model of human familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Nat Genet 11:389-394
31. Naveh-Many T, Silver J (1990) Regulation of parathyroid hormone gene expression by hypocalcemia, hypercalcemia and vitamin D in the rat. J Clin Invest 86:1313-1319
32. Naveh-Many T, Rahamimov R, Livni N, Silver J (1995) Parathyroid cell proliferation in normal and chronic renal failure rats. The effects of calcium, phosphate, and vitamin D. J Clin Invest 96:1786-1793
33. Yamamoto M, Igarashi T, Muramatsu M, Fukagawa M, Motokura T, Ogata E (1989) Hypocalcemia increases and hypercalcemia decreases the steady-state level of parathyroid hormone messenger RNA in the rat. J Clin Invest 83:1053-1056
34. Moallem E, Kilav R, Silver J, Naveh-Many T (1998) RNA-protein binding and post-transcriptional regulation of parathyroid hormone gene expression by calcium and phosphate. J Biol Chem 273:5253-5259
35. Yalcindag C, Silver J, Naveh-Many T (1999) Mechanism of increased parathyroid hormone mRNA in experimental uremia: roles of protein RNA binding and RNA degradation. J Am Soc Nephrol 10:2562-2568
36. Goldman R, Bassett SH (1954) Phosphorus excretion in renal failure. J Clin Invest 33:1623-1628
37. Slatopolsky E, Finch J, Denda M, Ritter C, Zhong M, Dusso A, MacDonald PN, Brown AJ (1996) Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro. J Clin Invest 97:2534-2540
38. Denda M, Finch J, Slatopolsky E (1996) Phosphorus accelerates the development of parathyroid hyperplasia and secondary hyperparathyroidism in rats with renal failure. Am J Kidney Dis 28:596-602
39. Tatsumi S, Segawa H, Morita K, Haga H, Kouda T, Yamamoto H, Inoue Y, Nii T, Katai K, Taketani Y, Miyamoto KI, Takeda E (1998) Molecular cloning and hormonal regulation of PiT-1, a sodium-dependent phosphate cotransporter from rat parathyroid glands. Endocrinology 139:1692-1699
40. Shinki T, Shimada H, Wakino S, Anazawa H, Hayashi M, Saruta T, DeLuca HF, Suda T (1997) Cloning and expression of rat 25-hydroxyvitamin D3-1alpha-hydroxylase cDNA. Proc Natl Acad Sci U S A 94:12920-12925
41. Kitanaka S, Takeyama K, Murayama A, Sato T, Okumura K, Nogami M, Hasegawa Y, Niimi H, Yanagisawa J, Tanaka T, Kato S (1998) Inactivating mutations in the 25-hydroxyvitamin D3 1alpha-hydroxylase gene in patients with pseudovitamin D-deficiency rickets. N Engl J Med 338:653-661
42. Yoshida T, Monkawa T, Tenenhouse HS, Goodyer P, Shinki T, Suda T, Wakino S, Hayashi M, Saruta T (1998) Two novel 1alpha-hydroxylase mutations in French-Canadians with vitamin D dependency rickets type I1. Kidney Int 54:1437-1443
43. Silver J, Russell J, Sherwood LM (1985) Regulation by vitamin D metabolites of messenger ribonucleic acid for preproparathyroid hormone in isolated bovine parathyroid cells. Proc Natl Acad Sci U S A 82:4270-4273
44. Silver J, Naveh-Many T, Mayer H, Schmelzer HJ, Popovtzer MM (1986) Regulation by vitamin D metabolites of parathyroid hormone gene transcription in vivo in the rat. J Clin Invest 78:1296-1301
45. Russell J, Silver J, Sherwood LM (1984) The effects of calcium and vitamin D metabolites on cytoplasmic mRNA coding for pre-proparathyroid hormone in isolated parathyroid cells. Trans Assoc Am Physicians 97:296-303
46. Naveh-Many T, Marx R, Keshet E, Pike JW, Silver J (1990) Regulation of 1,25-dihydroxyvitamin D3 receptor gene expression by 1,25-dihydroxyvitamin D3 in the parathyroid in vivo. J Clin Invest 86:1968-1975
47. 3 in the regulation of vitamin D receptor expression by rat parathyroid glands. Endocrinology 136:1419-1425
48. Patel SR, Ke HQ, Vanholder R, Koenig RJ, Hsu CH (1995) Inhibition of calcitriol receptor binding to vitamin D response elements by uremic toxins. J Clin Invest 96:50-59
49. 3 receptor density is associated with a more severe form of parathyroid hyperplasia in chronic uremic patients. J Clin Invest 92:1436-1443
50. Li YC, Pirro AE, Amling M, Delling G, Baron R, Bronson R, Demay MB (1997) Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. Proc Natl Acad Sci U S A 94:9831-9835
51. Amling M, Priemel M, Holzmann T, Chapin K, Rueger JM, Baron R, Demay MB (1999) Rescue of the skeletal phenotype of vitamin D receptor-ablated mice in the setting of normal mineral ion homeostasis: formal histomorphometric and biomechanical analyses. Endocrinology 140:4982-4987
52. Li YC, Amling M, Pirro AE, Priemel M, Meuse J, Baron R, Delling G, Demay MB (1998) Normalization of mineral ion homeostasis by dietary means prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in vitamin D receptor-ablated mice. Endocrinology 139:4391-4396
53. Brown EM, Gardner DG, Brennan MF, Marx SJ, Spiegel AM, Attie MF, Downs RW Jr, Doppman JL, Aurbach GD (1979) Calcium-regulated parathyroid hormone release in primary hyperparathyroidism: studies in vitro with dispersed parathyroid cells. Am J Med 66:923-931
54. Brown EM, Wilson RE, Eastmen RC, Pallotta J, Marynick S (1982) Abnormal regulation of parathyroid hormone release by calcium in secondary hyperparathyroidism due to chronic renal failure. J Clin Endocrinol Metab 54:172-179
55. Ramirez JA, Goodman WG, Gornbein J, Menezes C, Moulton L, Segre GV, Salusky IB (1993) Direct in vivo comparison of calcium-regulated parathyroid hormone secretion in normal volunteers and patients with secondary hyperparathyroidism. J Clin Endocrinol Metab 76:1489-1494
56. Sanchez CP, Goodman WG, Ramirez JA, Belin TR, Segre GV, Salusky IB (1995) Calcium-regulated parathyroid hormone secretion in adynamic renal osteodystrophy. Kidney Int 48:838-843
57. Goodman WG, Veldhuis JD, Belin TR, Jüppner H, Salusky IB (1997) Suppressive effect of calcium on parathyroid hormone release in adynamic renal osteodystrophy and secondary hyperparathyroidism. Kidney Int 51:1590-1595
58. Goodman WG, Veldhuis JD, Belin TR, Van Herle AJ, Jüppner H, Salusky IB (1998) Calcium-sensing by parathyroid glands in secondary hyperparathyroidism. J Clin Endocrinol Metab 83:2765-2772
59. Delmez JA, Tindira C, Grooms P, Dusso A, Windus DW, Slatopolsky E (1989) Parathyroid hormone suppression by intravenous 1,25-dihydroxyvitamin D. A role for increased sensitivity to calcium. J Clin Invest 83:1349-1355
60. Dunlay R, Rodriguez M, Felsenfeld AJ, Llach F (1989) Direct inhibitory effect of calcitriol on parathyroid function (sigmoidal curve) in dialysis. Kidney Int 36:1093-1098
61. Ouseph R, Leiser JD, Moe SM (1996) Calcitriol and the parathyroid hormone-ionized calcium curve: a comparison of methodologic approaches. J Am Soc Nephrol 7:497-505
62. Imanishi Y, Hosokawa Y, Yoshimoto K, Schipani E, Mallya S, Papanikolaou A, Kifor O, Tokura T, Sablosky M, Ledgard F, Gronowicz G, Wang TC, Schmidt EV, Hall C, Brown EM, Bronson R, Arnold A (2001) Primary hyperparathyroidism caused by parathyroid-targeted overexpression of cyclin D1 in transgenic mice. J Clin Invest 107:1093-1102
63. Arnold A, Brown MF, Ureña P, Gaz RD, Sarfati E, Drüeke TB (1995) Monoclonality of parathyroid tumors in chronic renal failure and in primary parathyroid hyperplasia. J Clin Invest 95:2047-2053
64. Dusso AS, Pavlopoulos T, Naumovich L, Lu Y, Finch J, Brown AJ, Morrissey J, Slatopolsky E (2001) p21(WAF1) and transforming growth factor-alpha mediate dietary phosphate regulation of parathyroid cell growth. Kidney Int 59:855-865
65. 2+-sensing receptor in primary and uremic secondary hyperparathyroidism. J Clin Endocrinol Metab 81:1598-1606
66. Farnebo F, Hoog A, Sandelin K, Larsson C, Farnebo LO (1998) Decreased expression of calcium-sensing receptor messenger ribonucleic acids in parathyroid adenomas. Surgery 124:1094-1098
67. Brown AJ, Zhong M, Finch J, Ritter C, McCracken R, Morrissey J, Slatopolsky E (1996) Rat calcium-sensing receptor is regulated by vitamin D but not by calcium. Am J Physiol 270:F454-F460
68. Massry SG, Coburn JW, Lee DBN, Jowsey J, Kleeman CR (1973) Skeletal resistance to parathyroid hormone in renal failure. Ann Intern Med 78:357-364
69. 3. J Lab Clin Med 94:152-157
70. Picton ML, Moore PR, Mawer EB, Houghton D, Freemont AJ, Hutchison AJ, Gokal R, Hoyland JA (2000) Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 58:1440-1449
71. Sanchez CP, Salusky IB, Kuizon BD, Abdella P, Jüppner H, Goodman WG (1998) Growth of long bones in renal failure: roles of hyperparathyroidism, growth hormone and calcitriol. Kidney Int 54:1879-1887
72. Hamdy NA, Kanis JA, Beneton MNC, Brown CB, Juttmann JR, Jordans JGM, Josse S, Meyrier A, Lins RL, Fairey IT (1995) Effect of alfacalcidol on natural course of renal bone disease in mild to moderate renal failure. BMJ 310:358-363
73. Coen G, Mazzaferro S, Ballanti P, Sardella D, Chicca S, Manni A, Bonucci E, Taggi F (1996) Renal bone disease in 76 patients with varying degrees of predialysis chronic renal failure: a cross-sectional study. Nephrol Dial Transplant 11:813-819
74. John MR, Goodman WG, Gao P, Cantor TL, Salusky IB, Jüppner H (1999) A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure. J Clin Endocrinol Metab 84:4287-4290
75. Malluche HH, Faugere MC (1992) Risk of adynamic bone disease in dialyzed patients. Kidney Int 42:S62-S67
76. Sherrard DJ, Ott SM, Maloney NA, Andress DL, Coburn JW (1983) Uremic osteodystrophy: classification, cause and treatment. In: Frame B, Potts J (eds) Clinical disorders of bone and mineral metabolism. Excerpta Medica, Amsterdam, p 254
77. Fournier A, Moriniere PH, Sebert JL, Dkhissi H, Atik A, Leflon P, Renaud H, Gueris J, Gregoire I, Idrissi A, Garabedian M (1986) Calcium carbonate, an aluminum-free agent for control of hyperphosphatemia, hypocalcemia and hyperparathyroidism in uremia. Kidney Int 29:S115-S119
78. Salusky IB, Coburn JW, Foley J, Nelson P, Fine RN (1986) Effects of oral calcium carbonate on control of serum phosphorus and changes in plasma aluminum levels after discontinuation of aluminum-containing gels in children receiving dialysis. J Pediatr 108:767-770
79. Slatopolsky E, Weerts C, Lopez-Hilker S, Norwood K, Zink M, Windus M, Delmez J (1986) Calcium carbonate is an effective phosphate binder in patients with chronic renal failure undergoing dialysis. N Engl J Med 315:157-161
80. Cushner HM, Copley JB, Lindberg JS, Foulks CJ (1988) Calcium citrate, a nonaluminum-containing phosphate-binding agent for treatment of CRF. Kidney Int 33:95-99
81. Mai ML, Emmett M, Sheikh MS, Santa Ana CA, Schiller L, Fordtran JS (1989) Calcium acetate, an effective phosphorus binder in patients with renal failure. Kidney Int 36:690-695
82. Schaefer K, Scheer J, Asmus G, Umlauf E, Hagemann J, von Herrath D (1991) The treatment uraemic hyperphosphataemia with calcium acetate and calcium carbonate: a comparative study. Nephrol Dial Transplant 6:171-175
83. Slatopolsky E, Weerts C, Thielan J, Horst RL, Harter H, Martin KJ (1984) Marked suppression of secondary hyperparathyroidism by intravenous administration of 1,25-dihydroxycholecalciferol in uremic patients. J Clin Invest 74:2136-2143
84. 3 pulse therapy. N Engl J Med 315:421-422
85. Quarles LD, Yohay DA, Carroll BA, Spritzer CE, Minda SA, Bartholomay D, Lobaugh BA (1994) Prospective trial of pulse oral versus intravenous calcitriol treatment of hyperparathyroidism in ESRD. Kidney Int 45:1710-1721
86. Fernandez E, Llach F (1996) Guidelines for dosing of intravenous calcitriol in dialysis patients with hyperparathyroidism. Nephrol Dial Transplant 11 Suppl 3:96-101
87. Pei Y, Hercz G, Greenwood C, Segre GV, Manuel A, Saiphoo C, Fenton S, Sherrard DJ (1995) Risk factors for renal osteodystrophy: a multivariant analysis. J Bone Miner Res 10:149-156
88. Frost HF (1963) Measurement of human bone formation by means of tetracycline labelling. Can J Biochem Biophys 41:31-38
89. Sherrard DJ (1986) Renal osteodystrophy. Semin Nephrol 6:56-67
90. Goodman WG, Coburn JW, Slatopolsky E, Salusky IB (1999) Renal osteodystrophy in adults and children. In: Favus MJ (ed) Primer on the metabolic bone diseases and disorders of mineral metabolism. Lippincott, Williams and Wilkins, Philadelphia, p 347
91. Hruska KA, Teitelbaum SL (1995) Renal osteodystrophy. N Engl J Med 333:166-174
92. Hercz G, Andress DL, Nebeker HG, Shinaberger JH, Sherrard DJ, Coburn JW (1988) Reversal of aluminum-related bone disease after substituting calcium carbonate for aluminum hydroxide. Am J Kidney Dis 11:70-75
93. Malluche HH, Smith AJ, Abreo K, Faugere MC (1984) The use of deferoxamine in the management of aluminium accumulation in bone in patients with renal failure. N Engl J Med 311:140-144
94. Goodman WG, Leite Duarte ME (1991) Aluminum: effects on bone and role in the pathogenesis of renal osteodystrophy. Miner Electrolyte Metab 17:221-232
95. Goodman WG, O'Connor J (1991) Aluminum alters calcium influx and efflux from bone in vitro. Kidney Int 39:602-607
96. Morrissey J, Rothstein M, Mayor G (1983) Suppression of parathyroid hormone secretion by aluminum. Kidney Int 23:699-704
97. Kurz P, Monier-Faugere MC, Bognar B, Werner E, Roth P, Vlachojannis J, Malluche HH (1994) Evidence for abnormal calcium homeostasis in patients with adynamic bone disease. Kidney Int 46:855-861
98. Mawad HW, Sawaya BP, Sarin R, Malluche HH (1999) Calcific uremic arteriolopathy in association with low turnover uremic bone disease. Clin Nephrol 52:160-166
99. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Salusky IB (2000) Coronary artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 342:1478-1483
100. Guérin AP, London GM, Marchais SJ, Metivier F (2000) Arterial stiffening and vascular calcifications in end-stage renal disease. Nephrol Dial Transplant 15:1014-1021
101. Kuizon BD, Goodman WG, Jüppner H, Boechat I, Nelson P, Gales B, Salusky IB (1998) Diminished linear growth during treatment with intermittent calcitriol and dialysis in children with chronic renal failure. Kidney Int 53:205-211
102. Atsumi K, Kushida K, Yamazaki K, Shimizu S, Ohmura A, Inoue T (1999) Risk factors for vertebral fractures in renal osteodystrophy. Am J Kidney Dis 33:287-293
103. Wernerson A, Svensson O, Reinholt FP (1989) Parathyroid cell number and size in hypercalcemic rats: a stereologic study employing modern unbiased estimators. J Bone Miner Res 4:705-713
104. Weinstein RS (2000) True strength. J Bone Miner Res 15:621-625
105. Krempien B, Mehls O, Ritz E (1974) Morphological studies on pathogenesis of epiphyseal slipping in uremic children. Virchows Arch A Pathol Anat Histol 362:129-143
106. Lanske B, Karaplis AC, Lee K, Luz A, Vortkamp A, Pirro A, Karperien M, Defize LHK, Ho C, Mulligan RC, Abou-Samra AB, Jüppner H, Segre GV, Kronenberg HM (1996) PTH/PTHrP receptor in early development and Indian hedgehog-regulated bone growth. Science 273:663-666
107. Vortkamp A, Lee K, Lanske B, Segre GV, Kronenberg HM, Tabin CJ (1996) Regulation of rate of cartilage differentiation by Indian hedgehog and PTH-related protein. Science 273:613-622
108. Karaplis AC, Luz A, Glowacki J, Bronson RT, Tybulewicz VLJ, Kronenberg HM, Mulligan RC (1994) Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289
109. Amizuka N, Warshawsky H, Henderson JE, Goltzman D, Karaplis AC (1994) Parathyroid hormone-related peptide-depleted mice show abnormal epiphyseal cartilage development and altered endochondral bone formation. J Cell Biol 126:1611-1623
110. Lee K, Lanske B, Karaplis AC, Deeds JD, Kohno H, Nissenson RA, Kronenberg HM, Segre GV (1996) Parathyroid hormone-related peptide delays terminal differentiation of chondrocytes during endochondral bone development. Endocrinology 137:5109-5118
111. Jobert A-S, Zhang P, Couvineau A, Bonaventure J, Roume J, Le Merrer M, Silve C (1998) Absence of functional receptors for parathyroid hormone and parathyroid hormone-related peptide in Blomstrand chondrodysplasia. J Clin Invest 102:34-40
112. Weir EC, Philbrick WM, Amling M, Neff LA, Baron R, Broadus AE (1996) Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Natl Acad Sci U S A 93:10240-10245
113. Schipani E, Kruse K, Jüppner H (1995) A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268:98-100
114. Schipani E, Langman CB, Parfitt AM, Jensen GS, Kikuchi S, Kooh S, Cole WG, Jüppner H (1996) Constitutively activated receptors for parathyroid hormone and parathyroid hormone related peptide in Jansen's metaphyseal chondrodysplasia. N Engl J Med 335:708-714
115. Cobo A, Lopez J M, Carbajo E, Santos F, Alvarez J, Fernandez M, Weruaga A (1999) Growth plate cartilage formation and resorption are differentially depressed in growth retarded uremic rats. J Am Soc Nephrol 10:971-979
116. Cobo A, Carbajo E, Santos F, Garcia E, Lopez JM (1996) Morphometry of uremic rat growth plate. Miner Electrolyte Metab 22:192-195
117. Mehls O, Ritz E, Hunziker EB, Eggli P, Heinrich U, Zapf J (1988) Improvement of growth and food utilization by recombinant human growth hormone in uremia. Kidney Int 33:45-52
118. Hanna JD, Santos F, Foreman JW, Chan JCM, Han VKM (1995) Insulin-like growth factor-I gene expression in the tibial epiphyseal growth plate of growth hormone-treated uremic rats. Kidney Int 47:1374-1382
119. Sanchez CP, Kuizon BD, Abdella PA, Jüppner H, Salusky IB, Goodman WG (2000) Impaired growth, delayed ossification, and reduced osteoclastic activity in the growth plate of calcium-supplemented rats with renal failure. Endocrinology 141:1536-1544
120. Ureña P, Mannstadt M, Hruby M, Ferreira A, Schmitt F, Silve C, Ardaillou R, Lacour B, Abou-Samra AB, Segre GV (1995) Parathyroidectomy does not prevent the renal PTH/PTHrP receptor down-regulation in uremic rats. Kidney Int 47:1797-1805
121. Ureña P, Ferreira A, Morieux C, Drüeke T, de Vernejoul MC (1996) PTH/PTHrP receptor mRNA is downregulated in epiphyseal cartilage growth plate of uraemic rats. Nephrol Dial Transplant 11:2008-2016
122. Ureña P, Kubrusly M, Mannstadt M, Hruby M, Trinh MM, Silve C, Lacour B, Abou-Samra AB, Segre GV, Drüeke TB (1994) The renal PTH/PTHrP receptor is down-regulated in rats with chronic renal failure. Kidney Int 45:605-611
123. Tonshoff B, Veldhuis JD, Heinrich U, Mehls O (1995) Deconvolution analysis of spontaneous nocturnal growth hormone secretion in prepubertal children with preterminal chronic renal failure and with end-stage renal disease. Pediatr Res 37:86-93
124. Samaan NA, Freeman RM (1970) Growth hormone levels in severe renal failure. Metabolism 19:102-113
125. Tonshoff B, Cronin MJ, Reichert M, Haffner D, Wingen AM, Blum WF, Mehls O. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood, and Members of the German Study Group for Growth Hormone Treatment in Chronic Renal Failure (1997) Reduced concentration of serum growth hormone (GH)-binding protein in children with chronic renal failure: correlation with GH insensitivity. J Clin Endocrinol Metab 82:1007-1013
126. Postel-Vinay MC, Tar A, Crosnier H, Broyer M, Rappaport R, Tonshoff B, Mehls O (1991) Plasma growth hormone-binding activity is low in uraemic children. Pediatr Nephrol 5:545-547
127. Baumann G (1996) Growth hormone binding protein and free growth hormone in chronic renal failure. Pediatr Nephrol 10:328-330
128. Tonshoff B, Eden S, Weiser E, Carlsson B, Robinson LC, Blum WF, Mehls O (1994) Reduced hepatic growth hormone (GH) receptor gene expression and increased plasma GH binding protein in experimental uremia. Kidney Int 45:1085-1092
129. Powell D, Liu F, Baker BK, Hintz RL, Lee PDK, Durham SK, Brewer E, Frane JW, Watkins SL, Hogg RJ (1997) Modulation of growth factors by growth hormone in children with chronic renal failure. Kidney Int 51:1970-1979
130. Ulinski T, Mohan S, Kiepe D, Blum WF, Wingen AM, Mehls O, Tonshoff B (2000) Serum insulin-like growth factor binding protein (IGFBP)-4 and IGFBP-5 in children with chronic renal failure: relationship to growth and glomerular filtration rate. The European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. German Study Group for Growth Hormone Treatment in Chronic Renal Failure. Pediatr Nephrol 14:589-597
131. Powell DR, Liu F, Baker BK, Hintz RL, Lee PD, Durham SK, Brewer ED, Frane JW, Watkins SL, Hogg RJ (1997) Modulation of growth factors by growth hormone in children with chronic renal failure. The Southwest Pediatric Nephrology Study Group. Kidney Int 51:1970-1979
132. Powell DR (1997) Effects of renal failure on the growth hormone-insulin-like growth factor axis. J Pediatr 131:S13-S16
133. Tonshoff B, Blum WF, Mehls O (1997) Derangements of the somatotropic hormone axis in chronic renal failure. Kidney Int Suppl 58:S106-S113
134. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S (2001) Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107:73-81
135. Richman C, Baylink DJ, Lang K, Dony C, Mohan S (1999) Recombinant human insulin-like growth factor-binding protein-5 stimulates bone formation parameters in vitro and in vivo. Endocrinology 140:4699-4705
136. Powell DR, Durham SK, Liu F, Baker BK, Lee PD, Watkins SL, Campbell PG, Brewer ED, Hintz RL, Hogg RJ (1998) The insulin-like growth factor axis and growth in children with chronic renal failure: a report of the Southwest Pediatric Nephrology Study Group. J Clin Endocrinol Metab 83:1654-1661
137. Edmondson SR, Baker NL, Oh J, Kovacs G, Werther GA, Mehls O (2000) Growth hormone receptor abundance in tibial growth plates of uremic rats: GH/IGF-I treatment. Kidney Int 58:62-70
138. Green J, Maor G (2000) Effect of metabolic acidosis on the growth hormone/IGF-I endocrine axis in skeletal growth centers. Kidney Int 57:2258-2267
139. Saggese G, Federico G, Cinquanta L (1993) In vitro effects of growth hormone and other hormones on chondrocytes and osteoblast-like cells. Acta Paediatr Suppl 391:54-59
140. 3 differentially regulates the production of insulin-like growth factor-I (IGF-I) and IGF-binding protein-4 in mouse osteoblasts. Endocrinology 129:3139-3146
141. 3 on cartilage growth in neonatal mice. Metab Bone Dis Relat Res 4:337-345
142. Weinreb M Jr, Gazit E, Weinreb MM (1986) Mandibular growth and histologic changes in condylar cartilage of rats intoxicated with vitamin D3 or 1,25(OH)2D3 and pair-fed (undernourished) rats. J Dent Res 65:1449-1452
143. Silbermann M, von der MK, Mirsky N, van Menxel M, Lewinson D (1987) Effects of increased doses of 1,25-dihydroxyvitamin D3 on matrix and DNA synthesis in condylar cartilage of suckling mice. Calcif Tissue Int 41:95-104
144. Kainer G, Nakano M, Massie FS Jr, Foreman JW, Chan JCM (1991) Hypercalciuria due to combined growth hormone and calcitriol therapy in uremia: effects of growth hormone on mineral homeostasis in 75% nephrectomized weanling rats. Pediatr Res 30:528-533
145. Salusky IB, Goodman WG, Coburn JW (2001) The renal osteodystrophies. In: DeGroot LJ, Jameson JL (eds) Endocrinology. WB Saunders, Philadelphia, p 1207